stella
beta
Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma — Stella
Recruiting
Back to Hepatocellular Carcinoma (HCC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov